Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Denmark / NCT04190589
Recruiting Not applicable

Prospective Study of Extended Robotic Right Hemicolectomy With Complete Mesocolic Excision for Cancer

NCT04190589 · tracked via the Priya Life Science Denmark tracker
Sponsor
Vejle Hospital
Phase
Not applicable
Started
2020-05-18
Last updated
2026-01-07

Condition(s) studied

Colorectal Cancer

Investigational drug(s) / intervention(s)

Robot-assisted laparoscopic extended right colectomy

Robot-assisted laparoscopic extended right colectomy: An extended right hemicolectomy with total mesocolic excision and meticulous central dissection as described by Hohenberger will be performed with the DaVinci Xi robot by one of two dedicated surgeons

Study summary

A single-center prospective study to elucidate whether extended robot-assisted right colectomy (e-RARC) performs as well as extended open right colectomy (e-ORC) in terms of specimen quality, and in addition, whether less postoperative morbidity and shorter length of stay (LOS) can be attained. Patients with colonic cancer near the right flexure or the oral part of the transverse colon will be compared excluding the most technically demanding and frail patients in both groups. A total of 40 patients undergoing e-RARC in a prospective series will be included and compared with 44 consecutive patients previously treated with e-ORC.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Suspected or verified colonic cancer visualized by colonoscopy and on CT in the anal part of the ascending colon, in the right flexure or in the oral 2/3 of the transverse colon * Patient is 18 years or older, legally competent and able to comprehend information and give consent * Tumor is UICC stage I-III on preop CT * Operation is elective Exclusion Criteria: * Previous major open intraabdominal surgery * Ileus or other acute abdominal condition * CT scan with suspicion of T4 tumor * RITA score \> 3 (Preop risk and frailty score) * BMI \> 35 kg/m2 * Project surgeon not available

Primary outcome measure(s)

  • Plane of dissection — 30 days
    As judged by pathologist (mesocolic/intramesocolic/intramuscular)
  • Lymph node count — 30 days
    Number of nodes in specimen, as determined by pathologist

Trial sites (1)

FacilityCityRegionStatus
Vejle Hospital, Department of Surgery Vejle Denmark Recruiting

More Vejle Hospital trials in Denmark

Optimising Mammography Screening Accuracy With Blood-based Biomarkers Enrolling by invitation
FRAME - Implementation of a PRO Measure to Inform Patient-Centered Survivorship Care in Oncology Outpatient Visits Recruiting
Proteomic Analysis on Myopic Children Using Orthokeratology Lenses With Good or Poor Myopic Control Active, not recruiting
Curative Chemoradiation of Low Rectal Cancer Active, not recruiting
Blood Based Risk Evaluation With AI for Targeted Primary Health Care in Early Lung Cancer Detection Recruiting

Other trials for the same condition

IMPROVE: Circulating Tumor DNA Analysis to Optimize Treatment for Patients With Colorectal Cancer Active, not recruiting
Adjuvant Low Dose Aspirin in Colorectal Cancer Active, not recruiting
Colorectal Omics and OfCS Proteoglycans Recruiting
RESPONSE: Colorectal Cancer Survivors' Follow-up Care - Now Digital and Need-based Recruiting
Low Versus Standard Intraabdominal Pressure in Robot-assisted Colorectal Cancer Surgery Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04190589 on ClinicalTrials.gov ↗ ← All trials in Denmark